[A phase II clinical trial of human urinary CSF (P-100) in pediatric patients].
Tsuchida
M
M
Ohara
A
A
Tsukimoto
I
I
Hanawa
Y
Y
Akatsuka
J
J
Hoshi
Y
Y
Ueda
Y
Y
Yamamoto
M
M
Akabane
T
T
Komiyama
J
J
D000293:Adolescent; D000380:Agranulocytosis / Q000139:chemically induced / Q000628:therapy*; D000970:Antineoplastic Agents / Q000009:adverse effects; D002648:Child; D002675:Child, Preschool; D003115:Colony-Stimulating Factors / Q000627:therapeutic use*; D004341:Drug Evaluation; D005260:Female; D016179:Granulocyte Colony-Stimulating Factor; D006098:Granulocytes / Q000473:pathology; D006801:Humans; D007223:Infant; D007564:Japan; D008297:Male; D015337:Multicenter Studies as Topic; D009369:Neoplasms / Q000188:drug therapy; D009503:Neutropenia / Q000628:therapy
D000970:Antineoplastic Agents; D003115:Colony-Stimulating Factors; D016179:Granulocyte Colony-Stimulating Factor